Report overview
The symptoms of IBS-C include abdominal pain and discomfort, along with changes in bowel function. Bloating and/or gas also may happen. Changes in bowel function may include straining, infrequent stools, hard or lumpy stools, and/or a feeling that the bowel does not empty completely.
This report contains market size and forecasts of Irritable Bowel Syndrome with Constipation Drugs in global, including the following market information:
Global Irritable Bowel Syndrome with Constipation Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Irritable Bowel Syndrome with Constipation Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Irritable Bowel Syndrome with Constipation Drugs companies in 2021 (%)
The global Irritable Bowel Syndrome with Constipation Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lubiprostone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Irritable Bowel Syndrome with Constipation Drugs include Nestle, Abbot Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis and Astellas Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Irritable Bowel Syndrome with Constipation Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Irritable Bowel Syndrome with Constipation Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Irritable Bowel Syndrome with Constipation Drugs Market Segment Percentages, by Type, 2021 (%)
Lubiprostone
Linaclotide
Stimulant Laxatives
Osmotic Laxatives
Others
Global Irritable Bowel Syndrome with Constipation Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Irritable Bowel Syndrome with Constipation Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Irritable Bowel Syndrome with Constipation Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Irritable Bowel Syndrome with Constipation Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Irritable Bowel Syndrome with Constipation Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Irritable Bowel Syndrome with Constipation Drugs revenues share in global market, 2021 (%)
Key companies Irritable Bowel Syndrome with Constipation Drugs sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Irritable Bowel Syndrome with Constipation Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nestle
Abbot Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis
Astellas Pharmaceuticals
